Large-Scale Study Details Devastating Patient Harms Associated with Blood Culture Contamination
Magnolia Medical Technologies shared a study detailing the clinical and financial impacts of blood culture contamination on patient safety.
Magnolia Medical Technologies shared a study detailing the clinical and financial impacts of blood culture contamination on patient safety.
Prenosis, Inc.is expanding its existing partnership with Roche Diagnostics that will to improve and expedite the clinical recognition of sepsis.
Findings confirm that T2 Biosystems’ magnetic resonance technology for identification of bloodstream infections provides faster time to detection and shorter hospital stays.
The technology will be based on QuantuMDx’s rapid cell/sample preparation technology, Capture-XT, and Ontera’s nanopore biosensor, currently utilized in its Sam and Duo Nano platforms.
Read MoreA new breed of diagnostic companies is rolling out technologies to tackle a growing and deadly health-care problem: antibiotic-resistant bugs
Read MoreT2 Biosystems has announced the appointment of diagnostics industry veteran John Sperzel as president and chief executive officer, succeeding John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read MoreRapid molecular diagnostics contribute to improved patient outcomes.
Read MoreBeckman Coulter and Dascena will collaborate to develop and commercialize a novel machine-learning-based algorithm for the detection of sepsis.
Read MoreGradientech’s QuickMIC is a precision tool for ultrarapid antibiotic susceptibility testing.
Read MoreTo detect emergent sepsis, the study aims to develop a rapid diagnostic based on multiple biomarkers.
Read MoreDisqver uses next-generation sequencing of cell-free DNA to detect more than 1,500 bacteria, DNA viruses, fungi, and parasites in a patient’s bloodstream.
Read MoreBeckman’s Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular biomarker for identifying patients with sepsis, or those at increased risk of developing sepsis.
Read MoreBD’s quality control media for platelet testing have been CE marked and cleared by FDA.
Read MoreThe World Health Organization has declared sepsis a global health priority; 80% of sepsis deaths in hospitals could be prevented with rapid diagnosis and treatment.
Read MoreA bedside test identifies infants with a genetic mutation of the mitochondrial DNA responsible for irreversible hearing loss as an adverse reaction to the antibiotic gentamicin.
Read MoreOffered as part of a routine CBC with differential test, the hematology-based solution alerts emergency department clinicians to the possibility of sepsis earlier than any other indicator.
Read MoreThe first FDA-cleared test to identify sepsis-causing bacteria from whole blood decreases time to diagnosis.
Read MoreBeckman Coulter has exclusively sponsored the Escavo Sepsis Clinical Guide, a mobile, point-of-care medical reference application for healthcare professionals who manage septic patients in acute-care settings.
Read More